AdvaMedDx Statement on the Introduction of the MODDERN Cures Act

You are here

AdvaMedDx Statement on the Introduction of the MODDERN Cures Act

November 28, 2011

WASHINGTON, D.C. Andrew Fish, executive director of AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) focused on diagnostics policy matters, released the following statement on the MODDERN Cures Act introduced by Rep. Leonard Lance (R-NJ):

“We applaud Rep. Lance for recognizing the importance of diagnostic tests and their role in critical aspects of health care, including development of personalized medicine. Current Medicare payment policies for diagnostics are severely flawed, and this bill would modernize Medicare reimbursement to better recognize the contribution of modern diagnostics to quality of patient care and better health outcomes.

“The ‘MODDERN Cures Act’ supports further discovery and innovation in diagnostics and more timely access for those in need by streamlining the inclusion of new diagnostics in Medicare, and ensuring appropriate reimbursement for diagnostic tests. We are hopeful this bill will gain wide support.”

For more information, please contact: Ashley McMaster @ (202) 434-7245


AdvaMedDx member companies produce advanced, in vitro diagnostic tests that facilitate evidence-based medicine, improve quality of patient care, enable early detection of disease and reduce overall health care costs. Functioning as an association within AdvaMed, AdvaMedDx is the only multi-faceted, policy organization that deals exclusively with issues facing in vitro diagnostic companies both domestically in the United States and abroad. For more information, visit